Emerging cardiovascular technology, trends in ambulatory care, provider and payer partnerships, and value-based arrangements create strategic opportunities to address service demand and cost pressures ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. One person dies of cardiovascular disease (CVD) every 34 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. For many hospitals, it’s a high-stakes scramble to keep ...
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that the Japan Patent Office ...
Boston Scientific BSX, a prominent global player in cardiovascular technology, is well-positioned to capitalize on the robust expansion of the cardiovascular devices market. According to a ...
Before selecting any clinical treatment or modality, a comprehensive and also unbiased review and understanding of the clinical evidence is critical for the best patient outcomes. Three examples of ...
A new position statement from the Cardiac Society of Australia and New Zealand (CSANZ) and the Australian Cardiovascular Health and Rehabilitation Association (ACRA) underscores telehealth as a ...
You may consider yourself an expert in affairs of the heart (or, like many of us, less than expert but determined to keep going), but can you work an EKG machine? How about defibrillator paddles? For ...
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
Jun. 10, 2025 8:35 AM ETCardio Diagnostics Holdings, Inc. (CDIO) “We are proud to support this important innovation from the University of Iowa ecosystem,” said Marie Kerbeshian, Ph.D., Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results